Review



recombinant rat s100a8 protein  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    MedChemExpress recombinant rat s100a8 protein
    Recombinant Rat S100a8 Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+s100a8/S100A8%2C+Rat/pm42349222-69-0-12
    Average 94 stars, based on 4 article reviews
    recombinant rat s100a8 protein - by Bioz Stars, 2026-11
    94/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: Colonic Engyodontium fungus triggers neutrophil antimicrobial activity to suppress Lactobacillus johnsonii –derived glutamic acid–maintained Tregs
    Article Snippet: .. Lactobacillus cultures were incubated in MRS medium containing a 1:1 mixture of recombinant S100A8 and S100A9 peptides (5 μg/mL each; HY-P71076, MCE) for 6 or 24 hours under anaerobic conditions. .. The bacterial suspension was orally transferred into mice pretreated with an antibiotic cocktail containing kanamycin (400 mg; catalog 25389-94-0), gentamicin (35 mg; catalog 1405-41-0), colistin (57 mg; catalog 1264-72-8), metronidazole (215 mg; catalog 443-48-1), vancomycin (45 mg; catalog 1404-93-9), and erythromycin (10 mg; catalog 114-07-8; all from Macklin) in 1 L of drinking water (CEGKMV-ABX), followed by 1.5% DSS.

    Recombinant:

    Article Title: Colonic Engyodontium fungus triggers neutrophil antimicrobial activity to suppress Lactobacillus johnsonii –derived glutamic acid–maintained Tregs
    Article Snippet: .. Lactobacillus cultures were incubated in MRS medium containing a 1:1 mixture of recombinant S100A8 and S100A9 peptides (5 μg/mL each; HY-P71076, MCE) for 6 or 24 hours under anaerobic conditions. .. The bacterial suspension was orally transferred into mice pretreated with an antibiotic cocktail containing kanamycin (400 mg; catalog 25389-94-0), gentamicin (35 mg; catalog 1405-41-0), colistin (57 mg; catalog 1264-72-8), metronidazole (215 mg; catalog 443-48-1), vancomycin (45 mg; catalog 1404-93-9), and erythromycin (10 mg; catalog 114-07-8; all from Macklin) in 1 L of drinking water (CEGKMV-ABX), followed by 1.5% DSS.

    Article Title: <scp>TRPA1</scp>deficiency aggravates dilated cardiomyopathy by promoting<scp>S100A8</scp>expression to induce<scp>M1</scp>macrophage polarization in rats
    Article Snippet: Correction added on July 18, 2023, after first Online publication: Author list of order changed and Author contribution section amended accordingly.. Abbreviations: ANP, atrial natriuretic peptide; BAX, BCL2Associated X; BCL2, Bcell lymphoma2; BMDM, bone marrow derived macrophage; BNP, brain natriuretic peptide; BW, body weight; CA, cinnamaldehyde; CCAS1, cleaved caspase1; cDCM, chagasic DCM; CIL1β, cleaved IL1β; CKMB, creatine kinasemyocardial band; COL1, collagen 1; CXCL9, CXC Motif Chemokine 9; DCM, dilated cardiomyopathy; DHE, dihydroethidium; DOX, doxorubicin; FS, fractional shortening; GEO, gene expression omnibus; GSEA, gene set enrichment analysis; H&E, hematoxylin and eosin; HF, heart failure; HIF1α, hypoxia inducible factor1α; HW, heart weight; iDCM, idiopathic DCM; IFNγ, interferonγ; IL, interleukin; IONS, inducible nitric oxide synthase; KO, knockout; LPS, lipopolysaccharide; LV, left ventricular; LVEF, left ventricle ejection fraction; LVIDd, left ventricular internal diameter at enddiastole; LVIDs, left ventricular internal diameter at endsystole; MCSF, macrophage colonystimulating factor; NLRP3, NODlike receptor protein 3; NOX, NADPH oxidases; NRCM, neonatal rat cardiomyocyte; PSR, picrosirius red staining; ROS, reactive oxygen species; SD, SpragueDawley; SOD2, superoxide dismutase 2;; TLR4, Tolllike receptor 4; TNF, tumor necrosis factor; TRPA1, transient receptor potential ankyrin 1.. 1Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, PR China 2Cardiovascular Research Institute, Wuhan University, Wuhan, PR China 3Hubei Key Laboratory of Cardiology, Wuhan, PR China



    Similar Products

    94
    Bio-Techne corporation recombinant mouse s100a8/s100a9 heterodimer protein, cf
    Recombinant Mouse S100a8/S100a9 Heterodimer Protein, Cf, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+s100a8/Recombinant+Mouse+S100A8%2FS100A9+Heterodimer+Protein%2C+CF/bio-techne+corporation___8916-s8
    Average 94 stars, based on 1 article reviews
    recombinant mouse s100a8/s100a9 heterodimer protein, cf - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    93
    R&D Systems recombinant mouse s100a8 a9 heterodimer
    a-d , Platelet responses measured following intraperitoneal injection of LPS (10 mg/kg) or sterile PBS in WT and Cgas -/- mice. a , Platelet activation measured by MFI of surface CD62P expression on circulating CD41 platelets. b , Platelet-neutrophil aggregates quantified as CD41 fluorescence intensity on CD11b positive - Ly6G positive population. c , Platelet-monocytes aggregates quantified as CD41 fluorescence intensity on CD11b positive - Ly6G negative population. d , Relative platelet counts normalized to PBS-treated controls. e-h , Inflammatory platelet parameters measured 3 hours following LPS challenge. e , Cleaved caspase-1 measured by MFI of FLICA staining within platelet population. f , <t>Plasma</t> <t>S100A8/A9</t> concentrations. g , Platelet phosphatidylserine exposure measured by Annexin V staining within platelet population. h , Plasma thrombin-antithrombin (TAT) complex concentrations. Data are presented as mean ± SD. Each symbol represents one mouse. n = 3-8 biologically independent mice per group. Statistical significance was determined using ordinary two-way ANOVA followed by Fisher’s least significant difference (LSD) multiple-comparisons test. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; ns, not significant.
    Recombinant Mouse S100a8 A9 Heterodimer, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+s100a8/Recombinant+Mouse+S100A8%2FS100A9+Heterodimer+Protein%2C+CF/bio_rxiv__64898__2026__11__02__763723-197-15-19
    Average 93 stars, based on 1 article reviews
    recombinant mouse s100a8 a9 heterodimer - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    MedChemExpress recombinant rat s100a8 protein
    a-d , Platelet responses measured following intraperitoneal injection of LPS (10 mg/kg) or sterile PBS in WT and Cgas -/- mice. a , Platelet activation measured by MFI of surface CD62P expression on circulating CD41 platelets. b , Platelet-neutrophil aggregates quantified as CD41 fluorescence intensity on CD11b positive - Ly6G positive population. c , Platelet-monocytes aggregates quantified as CD41 fluorescence intensity on CD11b positive - Ly6G negative population. d , Relative platelet counts normalized to PBS-treated controls. e-h , Inflammatory platelet parameters measured 3 hours following LPS challenge. e , Cleaved caspase-1 measured by MFI of FLICA staining within platelet population. f , <t>Plasma</t> <t>S100A8/A9</t> concentrations. g , Platelet phosphatidylserine exposure measured by Annexin V staining within platelet population. h , Plasma thrombin-antithrombin (TAT) complex concentrations. Data are presented as mean ± SD. Each symbol represents one mouse. n = 3-8 biologically independent mice per group. Statistical significance was determined using ordinary two-way ANOVA followed by Fisher’s least significant difference (LSD) multiple-comparisons test. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; ns, not significant.
    Recombinant Rat S100a8 Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+s100a8/S100A8%2C+Rat/pm42349222-69-0-12
    Average 94 stars, based on 1 article reviews
    recombinant rat s100a8 protein - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    93
    R&D Systems recombinant mouse s100a8 a9 heterodimer protein
    a-d , Platelet responses measured following intraperitoneal injection of LPS (10 mg/kg) or sterile PBS in WT and Cgas -/- mice. a , Platelet activation measured by MFI of surface CD62P expression on circulating CD41 platelets. b , Platelet-neutrophil aggregates quantified as CD41 fluorescence intensity on CD11b positive - Ly6G positive population. c , Platelet-monocytes aggregates quantified as CD41 fluorescence intensity on CD11b positive - Ly6G negative population. d , Relative platelet counts normalized to PBS-treated controls. e-h , Inflammatory platelet parameters measured 3 hours following LPS challenge. e , Cleaved caspase-1 measured by MFI of FLICA staining within platelet population. f , <t>Plasma</t> <t>S100A8/A9</t> concentrations. g , Platelet phosphatidylserine exposure measured by Annexin V staining within platelet population. h , Plasma thrombin-antithrombin (TAT) complex concentrations. Data are presented as mean ± SD. Each symbol represents one mouse. n = 3-8 biologically independent mice per group. Statistical significance was determined using ordinary two-way ANOVA followed by Fisher’s least significant difference (LSD) multiple-comparisons test. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; ns, not significant.
    Recombinant Mouse S100a8 A9 Heterodimer Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+s100a8/Recombinant+Mouse+S100A8%2FS100A9+Heterodimer+Protein%2C+CF/pm42264451-82-17-26
    Average 93 stars, based on 1 article reviews
    recombinant mouse s100a8 a9 heterodimer protein - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    R&D Systems recombinant human s100a8 a9 heterodimer protein
    a-d , Platelet responses measured following intraperitoneal injection of LPS (10 mg/kg) or sterile PBS in WT and Cgas -/- mice. a , Platelet activation measured by MFI of surface CD62P expression on circulating CD41 platelets. b , Platelet-neutrophil aggregates quantified as CD41 fluorescence intensity on CD11b positive - Ly6G positive population. c , Platelet-monocytes aggregates quantified as CD41 fluorescence intensity on CD11b positive - Ly6G negative population. d , Relative platelet counts normalized to PBS-treated controls. e-h , Inflammatory platelet parameters measured 3 hours following LPS challenge. e , Cleaved caspase-1 measured by MFI of FLICA staining within platelet population. f , <t>Plasma</t> <t>S100A8/A9</t> concentrations. g , Platelet phosphatidylserine exposure measured by Annexin V staining within platelet population. h , Plasma thrombin-antithrombin (TAT) complex concentrations. Data are presented as mean ± SD. Each symbol represents one mouse. n = 3-8 biologically independent mice per group. Statistical significance was determined using ordinary two-way ANOVA followed by Fisher’s least significant difference (LSD) multiple-comparisons test. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; ns, not significant.
    Recombinant Human S100a8 A9 Heterodimer Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+s100a8/Recombinant+Human+S100A8%2FS100A9+Heterodimer+Protein%2C+CF/pm42264451-82-5-14
    Average 94 stars, based on 1 article reviews
    recombinant human s100a8 a9 heterodimer protein - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Bio-Techne corporation recombinant human s100a8/s100a9 heterodimer protein, cf
    a-d , Platelet responses measured following intraperitoneal injection of LPS (10 mg/kg) or sterile PBS in WT and Cgas -/- mice. a , Platelet activation measured by MFI of surface CD62P expression on circulating CD41 platelets. b , Platelet-neutrophil aggregates quantified as CD41 fluorescence intensity on CD11b positive - Ly6G positive population. c , Platelet-monocytes aggregates quantified as CD41 fluorescence intensity on CD11b positive - Ly6G negative population. d , Relative platelet counts normalized to PBS-treated controls. e-h , Inflammatory platelet parameters measured 3 hours following LPS challenge. e , Cleaved caspase-1 measured by MFI of FLICA staining within platelet population. f , <t>Plasma</t> <t>S100A8/A9</t> concentrations. g , Platelet phosphatidylserine exposure measured by Annexin V staining within platelet population. h , Plasma thrombin-antithrombin (TAT) complex concentrations. Data are presented as mean ± SD. Each symbol represents one mouse. n = 3-8 biologically independent mice per group. Statistical significance was determined using ordinary two-way ANOVA followed by Fisher’s least significant difference (LSD) multiple-comparisons test. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; ns, not significant.
    Recombinant Human S100a8/S100a9 Heterodimer Protein, Cf, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+s100a8/Recombinant+Human+S100A8%2FS100A9+Heterodimer+Protein%2C+CF/bio-techne+corporation___8226-s8
    Average 94 stars, based on 1 article reviews
    recombinant human s100a8/s100a9 heterodimer protein, cf - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    93
    R&D Systems s100a8 9
    <t>Increased</t> <t>S100A8/9</t> expression in the skin and serum of patients with BP and AD. ( a ) Immunohistochemical analysis with anti-S100A8/9 antibody showing the expression of S100A8/9 in keratinocytes and infiltrating inflammatory cells of lesional skin of patients with BP and AD. S100A8/9 expression was not observed in the healthy skin. Scale bar: 100 μm. (b) Quantification of the expression level of S100A8/9. (control, n = 2; BP, n = 5; AD n = 2). Inter-patient heterogeneity of the expression level of S100A8/9 was observed in the BP skin samples, and representative images of both low and high S100A8/9 expression were shown in A. (c) ELISA analysis showing increased S100A8/9 concentrations in the serum of patients with BP. (control, n = 8; BP, n = 16; P = .0087, Mann-Whitney test). Data are reported as mean ± SD. AD, atopic dermatitis; BP, bullous pemphigoid.
    S100a8 9, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+s100a8/Recombinant+Mouse+S100A8+Protein%2C+CF/pmc13098576-222-9-12
    Average 93 stars, based on 1 article reviews
    s100a8 9 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    R&D Systems recombinant human s100a8 a9 protein
    Klebsiella pneumoniae infection directly <t>induces</t> <t>S100A8/A9</t> expression and secretion in HBE cells. Primary HBE cells were infected with WT K. pneumoniae or an isogenic acapsular mutant (Δ cps ). (A,B) Expression of S100A8 and S100A9 was determined by qRT-PCR at 8 h post-infection with various MOIs of K. pneumoniae , or 100 MOI K. pneumoniae for 4–12 h (C,D) . Data are normalized to the housekeeping gene GAPDH and expressed as fold change relative to uninfected control cells. (E) Secretion of S100A8/A9 heterodimer induced by WT K. pneumoniae and the isogenic Δ cps mutant at indicated MOIs after 24 h. All data are presented as mean ± SEM of three independent experiments. * p < 0.05, ** p < 0.01 vs. uninfected cells (A–D) . Statistical differences between the WT and Δ cps groups were determined by Two-way ANOVA followed by Tukey’s post-hoc test. * p < 0.05 compared between strains at the same MOI (E) .
    Recombinant Human S100a8 A9 Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+s100a8/Recombinant+Human+S100A8+Protein%2C+CF/pmc12992257-51-9-13
    Average 94 stars, based on 1 article reviews
    recombinant human s100a8 a9 protein - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    R&D Systems s100a8 a9 recombinant protein
    Klebsiella pneumoniae infection directly <t>induces</t> <t>S100A8/A9</t> expression and secretion in HBE cells. Primary HBE cells were infected with WT K. pneumoniae or an isogenic acapsular mutant (Δ cps ). (A,B) Expression of S100A8 and S100A9 was determined by qRT-PCR at 8 h post-infection with various MOIs of K. pneumoniae , or 100 MOI K. pneumoniae for 4–12 h (C,D) . Data are normalized to the housekeeping gene GAPDH and expressed as fold change relative to uninfected control cells. (E) Secretion of S100A8/A9 heterodimer induced by WT K. pneumoniae and the isogenic Δ cps mutant at indicated MOIs after 24 h. All data are presented as mean ± SEM of three independent experiments. * p < 0.05, ** p < 0.01 vs. uninfected cells (A–D) . Statistical differences between the WT and Δ cps groups were determined by Two-way ANOVA followed by Tukey’s post-hoc test. * p < 0.05 compared between strains at the same MOI (E) .
    S100a8 A9 Recombinant Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+s100a8/Recombinant+Human+S100A8%2FS100A9+Heterodimer+Protein%2C+CF/pm41758936-395-9-14
    Average 94 stars, based on 1 article reviews
    s100a8 a9 recombinant protein - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    a-d , Platelet responses measured following intraperitoneal injection of LPS (10 mg/kg) or sterile PBS in WT and Cgas -/- mice. a , Platelet activation measured by MFI of surface CD62P expression on circulating CD41 platelets. b , Platelet-neutrophil aggregates quantified as CD41 fluorescence intensity on CD11b positive - Ly6G positive population. c , Platelet-monocytes aggregates quantified as CD41 fluorescence intensity on CD11b positive - Ly6G negative population. d , Relative platelet counts normalized to PBS-treated controls. e-h , Inflammatory platelet parameters measured 3 hours following LPS challenge. e , Cleaved caspase-1 measured by MFI of FLICA staining within platelet population. f , Plasma S100A8/A9 concentrations. g , Platelet phosphatidylserine exposure measured by Annexin V staining within platelet population. h , Plasma thrombin-antithrombin (TAT) complex concentrations. Data are presented as mean ± SD. Each symbol represents one mouse. n = 3-8 biologically independent mice per group. Statistical significance was determined using ordinary two-way ANOVA followed by Fisher’s least significant difference (LSD) multiple-comparisons test. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; ns, not significant.

    Journal: bioRxiv

    Article Title: cGAS integrates Toll-like receptor signaling in platelets to promote thromboinflammation

    doi: 10.64898/2026.11.02.763723

    Figure Lengend Snippet: a-d , Platelet responses measured following intraperitoneal injection of LPS (10 mg/kg) or sterile PBS in WT and Cgas -/- mice. a , Platelet activation measured by MFI of surface CD62P expression on circulating CD41 platelets. b , Platelet-neutrophil aggregates quantified as CD41 fluorescence intensity on CD11b positive - Ly6G positive population. c , Platelet-monocytes aggregates quantified as CD41 fluorescence intensity on CD11b positive - Ly6G negative population. d , Relative platelet counts normalized to PBS-treated controls. e-h , Inflammatory platelet parameters measured 3 hours following LPS challenge. e , Cleaved caspase-1 measured by MFI of FLICA staining within platelet population. f , Plasma S100A8/A9 concentrations. g , Platelet phosphatidylserine exposure measured by Annexin V staining within platelet population. h , Plasma thrombin-antithrombin (TAT) complex concentrations. Data are presented as mean ± SD. Each symbol represents one mouse. n = 3-8 biologically independent mice per group. Statistical significance was determined using ordinary two-way ANOVA followed by Fisher’s least significant difference (LSD) multiple-comparisons test. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; ns, not significant.

    Article Snippet: We used, LPS from Escherichia coli O111:B4 (Sigma-Aldrich, L2630), Pam3CSK4 (InvivoGen, tlrl-pms), flagellin (InvivoGen, tlrl-pbsfla), recombinant mouse S100A8/A9 heterodimer (R&D Systems, 8916-S8), cross-linked collagen-related peptide (CRP-XL; CambCol Laboratories Ltd., AB110421M), mouse PAR4-activating peptide AYPGKF-OH (Cayman Chemical, 27132), human PAR1-activating peptide TRAP-6 amide trifluoroacetate (SFLLRN-NH2; Bachem Americas, H-2936.0005BA) H-151 (MedChemExpress, HY-112693), and RU360 (MilliporeSigma, 557440) were used as indicated.

    Techniques: Injection, Sterility, Activation Assay, Expressing, Fluorescence, Staining, Clinical Proteomics, Annexin V Staining Assay

    Cgas -/- recipient mice were depleted of endogenous platelets and reconstituted with either donor WT or Cgas -/- platelets prior to intraperitoneal LPS challenge (10 mg/kg). Plasma and platelet parameters were assessed 1 hour after LPS administration. a-d , Plasma concentrations of a , CCL5, b , TNF-α, c , IL-6 and d , S100A8/A9. e , Platelet activation quantified by surface CD62P expression on circulating platelets. f , Platelet-neutrophil aggregates quantified as CD41 mean fluorescence intensity on CD11b positive - Ly6G positive population. g , Platelet phosphatidylserine exposure measured by Annexin V staining. f , Plasma thrombin-antithrombin (TAT) complex concentrations. Data are presented as mean ± SD. Each symbol represents one transfused mouse. n = 4-6 biologically independent mice per group. Statistical analyses were performed using an ordinary two-tailed unpaired Mann-Whitney test. *P < 0.05; **P < 0.01; ns, not significant.

    Journal: bioRxiv

    Article Title: cGAS integrates Toll-like receptor signaling in platelets to promote thromboinflammation

    doi: 10.64898/2026.11.02.763723

    Figure Lengend Snippet: Cgas -/- recipient mice were depleted of endogenous platelets and reconstituted with either donor WT or Cgas -/- platelets prior to intraperitoneal LPS challenge (10 mg/kg). Plasma and platelet parameters were assessed 1 hour after LPS administration. a-d , Plasma concentrations of a , CCL5, b , TNF-α, c , IL-6 and d , S100A8/A9. e , Platelet activation quantified by surface CD62P expression on circulating platelets. f , Platelet-neutrophil aggregates quantified as CD41 mean fluorescence intensity on CD11b positive - Ly6G positive population. g , Platelet phosphatidylserine exposure measured by Annexin V staining. f , Plasma thrombin-antithrombin (TAT) complex concentrations. Data are presented as mean ± SD. Each symbol represents one transfused mouse. n = 4-6 biologically independent mice per group. Statistical analyses were performed using an ordinary two-tailed unpaired Mann-Whitney test. *P < 0.05; **P < 0.01; ns, not significant.

    Article Snippet: We used, LPS from Escherichia coli O111:B4 (Sigma-Aldrich, L2630), Pam3CSK4 (InvivoGen, tlrl-pms), flagellin (InvivoGen, tlrl-pbsfla), recombinant mouse S100A8/A9 heterodimer (R&D Systems, 8916-S8), cross-linked collagen-related peptide (CRP-XL; CambCol Laboratories Ltd., AB110421M), mouse PAR4-activating peptide AYPGKF-OH (Cayman Chemical, 27132), human PAR1-activating peptide TRAP-6 amide trifluoroacetate (SFLLRN-NH2; Bachem Americas, H-2936.0005BA) H-151 (MedChemExpress, HY-112693), and RU360 (MilliporeSigma, 557440) were used as indicated.

    Techniques: Clinical Proteomics, Activation Assay, Expressing, Fluorescence, Annexin V Staining Assay, Two Tailed Test, MANN-WHITNEY

    ( a ) or phosphatidylserine exposure ( b ) on WT and Cgas -/- platelets following stimulation with LPS. c, d , Surface CD62P expression on ( c ), or Cleaved Caspase-1 measured by FLICA mean fluorescence intensity in ( d ) WT and Cgas -/- platelets following stimulation with S100A8/A9. e Surface CD62P expression on WT platelets stimulated with LPS and H151. f Cleaved Caspase-1 measured by FLICA mean fluorescence intensity in WT platelets stimulated with S100A8/A9 and H151. Data are presented as mean ± SD of 3-4 mice per group in at least two independent experiments. Statistical significance was determined using ordinary two-way ANOVA followed by Fisher’s least significant difference (LSD) multiple-comparisons test for experiments involving multiple groups and repeated-measures one-way ANOVA followed by Dunnett’s multiple-comparisons test for e,f . Comparisons between unstimulated and stimulated platelets from the same mouse were analyzed using paired statistical tests, as indicated in the figure. P < 0.05 (*), P < 0.01 (**); ns, not significant.

    Journal: bioRxiv

    Article Title: cGAS integrates Toll-like receptor signaling in platelets to promote thromboinflammation

    doi: 10.64898/2026.11.02.763723

    Figure Lengend Snippet: ( a ) or phosphatidylserine exposure ( b ) on WT and Cgas -/- platelets following stimulation with LPS. c, d , Surface CD62P expression on ( c ), or Cleaved Caspase-1 measured by FLICA mean fluorescence intensity in ( d ) WT and Cgas -/- platelets following stimulation with S100A8/A9. e Surface CD62P expression on WT platelets stimulated with LPS and H151. f Cleaved Caspase-1 measured by FLICA mean fluorescence intensity in WT platelets stimulated with S100A8/A9 and H151. Data are presented as mean ± SD of 3-4 mice per group in at least two independent experiments. Statistical significance was determined using ordinary two-way ANOVA followed by Fisher’s least significant difference (LSD) multiple-comparisons test for experiments involving multiple groups and repeated-measures one-way ANOVA followed by Dunnett’s multiple-comparisons test for e,f . Comparisons between unstimulated and stimulated platelets from the same mouse were analyzed using paired statistical tests, as indicated in the figure. P < 0.05 (*), P < 0.01 (**); ns, not significant.

    Article Snippet: We used, LPS from Escherichia coli O111:B4 (Sigma-Aldrich, L2630), Pam3CSK4 (InvivoGen, tlrl-pms), flagellin (InvivoGen, tlrl-pbsfla), recombinant mouse S100A8/A9 heterodimer (R&D Systems, 8916-S8), cross-linked collagen-related peptide (CRP-XL; CambCol Laboratories Ltd., AB110421M), mouse PAR4-activating peptide AYPGKF-OH (Cayman Chemical, 27132), human PAR1-activating peptide TRAP-6 amide trifluoroacetate (SFLLRN-NH2; Bachem Americas, H-2936.0005BA) H-151 (MedChemExpress, HY-112693), and RU360 (MilliporeSigma, 557440) were used as indicated.

    Techniques: Expressing, Fluorescence

    Increased S100A8/9 expression in the skin and serum of patients with BP and AD. ( a ) Immunohistochemical analysis with anti-S100A8/9 antibody showing the expression of S100A8/9 in keratinocytes and infiltrating inflammatory cells of lesional skin of patients with BP and AD. S100A8/9 expression was not observed in the healthy skin. Scale bar: 100 μm. (b) Quantification of the expression level of S100A8/9. (control, n = 2; BP, n = 5; AD n = 2). Inter-patient heterogeneity of the expression level of S100A8/9 was observed in the BP skin samples, and representative images of both low and high S100A8/9 expression were shown in A. (c) ELISA analysis showing increased S100A8/9 concentrations in the serum of patients with BP. (control, n = 8; BP, n = 16; P = .0087, Mann-Whitney test). Data are reported as mean ± SD. AD, atopic dermatitis; BP, bullous pemphigoid.

    Journal: JID Innovations

    Article Title: A neuroimmune axis linking S100A8/9 to itch sensitization in both bullous pemphigoid and atopic dermatitis

    doi: 10.1016/j.xjidi.2026.100470

    Figure Lengend Snippet: Increased S100A8/9 expression in the skin and serum of patients with BP and AD. ( a ) Immunohistochemical analysis with anti-S100A8/9 antibody showing the expression of S100A8/9 in keratinocytes and infiltrating inflammatory cells of lesional skin of patients with BP and AD. S100A8/9 expression was not observed in the healthy skin. Scale bar: 100 μm. (b) Quantification of the expression level of S100A8/9. (control, n = 2; BP, n = 5; AD n = 2). Inter-patient heterogeneity of the expression level of S100A8/9 was observed in the BP skin samples, and representative images of both low and high S100A8/9 expression were shown in A. (c) ELISA analysis showing increased S100A8/9 concentrations in the serum of patients with BP. (control, n = 8; BP, n = 16; P = .0087, Mann-Whitney test). Data are reported as mean ± SD. AD, atopic dermatitis; BP, bullous pemphigoid.

    Article Snippet: Chemicals used are listed as follows: S100A8, S100A9, and S100A8/9 (100 ng/ml, R&D Systems, 9877-S8, 2065-S9, 8916-S8), Bam8-22 (1 μM, custom synthesized by Genscript), and capsaicin (Sigma M2028, 1 μM).

    Techniques: Expressing, Immunohistochemical staining, Control, Enzyme-linked Immunosorbent Assay, MANN-WHITNEY

    S100A8/9 directly activates small-diameter, nociceptive DRG sensory neurons. ( a ) Representative fluorescent images of cultured DRG sensory neurons isolated from Pirt GCaMP3/+ mice before and after S100A8/9 (100 ng/ml) application. Arrows point to sensory neurons showing increased GCaMP3 fluorescence levels after S100A8/9 application. (b) Histogram showing size distribution of S100A8/9-responsive neurons. (c–e) Representative traces of DRG neurons evoked by indicated chemicals, including S100A8/9 (100 ng/ml), S100A8 (100 ng/ml), S100A9 (100 ng/ml), capsaicin (1 μM), and KCl (75 mM) in a calcium imaging assay. All S100A8/9-sensitive neurons responded to capsaicin and KCl. The majority of S100A8- and S100A9-responsive neurons also responded to S100A8/9. The three different colors (Red, Green, and Blue) represent individual cells in C-E. (f) TAK-242 inhibited S100A8/9-induced calcium responses in sensory neurons. (n = 3 for both groups P = .018, Welch’s t -test). Data are reported as mean ± SD. AD, atopic dermatitis; BP, bullous pemphigoid; DRG, dorsal root ganglia.

    Journal: JID Innovations

    Article Title: A neuroimmune axis linking S100A8/9 to itch sensitization in both bullous pemphigoid and atopic dermatitis

    doi: 10.1016/j.xjidi.2026.100470

    Figure Lengend Snippet: S100A8/9 directly activates small-diameter, nociceptive DRG sensory neurons. ( a ) Representative fluorescent images of cultured DRG sensory neurons isolated from Pirt GCaMP3/+ mice before and after S100A8/9 (100 ng/ml) application. Arrows point to sensory neurons showing increased GCaMP3 fluorescence levels after S100A8/9 application. (b) Histogram showing size distribution of S100A8/9-responsive neurons. (c–e) Representative traces of DRG neurons evoked by indicated chemicals, including S100A8/9 (100 ng/ml), S100A8 (100 ng/ml), S100A9 (100 ng/ml), capsaicin (1 μM), and KCl (75 mM) in a calcium imaging assay. All S100A8/9-sensitive neurons responded to capsaicin and KCl. The majority of S100A8- and S100A9-responsive neurons also responded to S100A8/9. The three different colors (Red, Green, and Blue) represent individual cells in C-E. (f) TAK-242 inhibited S100A8/9-induced calcium responses in sensory neurons. (n = 3 for both groups P = .018, Welch’s t -test). Data are reported as mean ± SD. AD, atopic dermatitis; BP, bullous pemphigoid; DRG, dorsal root ganglia.

    Article Snippet: Chemicals used are listed as follows: S100A8, S100A9, and S100A8/9 (100 ng/ml, R&D Systems, 9877-S8, 2065-S9, 8916-S8), Bam8-22 (1 μM, custom synthesized by Genscript), and capsaicin (Sigma M2028, 1 μM).

    Techniques: Cell Culture, Isolation, Fluorescence, Imaging

    S100A8/9 potentiate histamine-induced itch. ( a ) Subcutaneous injection of S100A8/9 (20 μg/ml) into the nape of the neck of wild-type mice does not induce scratching behavior. (n = 7 for both groups, P = .97, Welch’s t test). (b) Co-injection of S100A8/9 increased histamine (20 mM)-induced scratching behavior. (n = 11 for both groups, P = .038, Welch’s t test). Data are reported as mean ± SD.

    Journal: JID Innovations

    Article Title: A neuroimmune axis linking S100A8/9 to itch sensitization in both bullous pemphigoid and atopic dermatitis

    doi: 10.1016/j.xjidi.2026.100470

    Figure Lengend Snippet: S100A8/9 potentiate histamine-induced itch. ( a ) Subcutaneous injection of S100A8/9 (20 μg/ml) into the nape of the neck of wild-type mice does not induce scratching behavior. (n = 7 for both groups, P = .97, Welch’s t test). (b) Co-injection of S100A8/9 increased histamine (20 mM)-induced scratching behavior. (n = 11 for both groups, P = .038, Welch’s t test). Data are reported as mean ± SD.

    Article Snippet: Chemicals used are listed as follows: S100A8, S100A9, and S100A8/9 (100 ng/ml, R&D Systems, 9877-S8, 2065-S9, 8916-S8), Bam8-22 (1 μM, custom synthesized by Genscript), and capsaicin (Sigma M2028, 1 μM).

    Techniques: Injection

    Klebsiella pneumoniae infection directly induces S100A8/A9 expression and secretion in HBE cells. Primary HBE cells were infected with WT K. pneumoniae or an isogenic acapsular mutant (Δ cps ). (A,B) Expression of S100A8 and S100A9 was determined by qRT-PCR at 8 h post-infection with various MOIs of K. pneumoniae , or 100 MOI K. pneumoniae for 4–12 h (C,D) . Data are normalized to the housekeeping gene GAPDH and expressed as fold change relative to uninfected control cells. (E) Secretion of S100A8/A9 heterodimer induced by WT K. pneumoniae and the isogenic Δ cps mutant at indicated MOIs after 24 h. All data are presented as mean ± SEM of three independent experiments. * p < 0.05, ** p < 0.01 vs. uninfected cells (A–D) . Statistical differences between the WT and Δ cps groups were determined by Two-way ANOVA followed by Tukey’s post-hoc test. * p < 0.05 compared between strains at the same MOI (E) .

    Journal: Frontiers in Microbiology

    Article Title: Klebsiella pneumoniae infection induces an S100A8/A9-mediated autocrine loop in human airway epithelium to amplify inflammation

    doi: 10.3389/fmicb.2026.1768140

    Figure Lengend Snippet: Klebsiella pneumoniae infection directly induces S100A8/A9 expression and secretion in HBE cells. Primary HBE cells were infected with WT K. pneumoniae or an isogenic acapsular mutant (Δ cps ). (A,B) Expression of S100A8 and S100A9 was determined by qRT-PCR at 8 h post-infection with various MOIs of K. pneumoniae , or 100 MOI K. pneumoniae for 4–12 h (C,D) . Data are normalized to the housekeeping gene GAPDH and expressed as fold change relative to uninfected control cells. (E) Secretion of S100A8/A9 heterodimer induced by WT K. pneumoniae and the isogenic Δ cps mutant at indicated MOIs after 24 h. All data are presented as mean ± SEM of three independent experiments. * p < 0.05, ** p < 0.01 vs. uninfected cells (A–D) . Statistical differences between the WT and Δ cps groups were determined by Two-way ANOVA followed by Tukey’s post-hoc test. * p < 0.05 compared between strains at the same MOI (E) .

    Article Snippet: For S100A8/A9 stimulating experiment, cells were incubated with endotoxin-free recombinant human S100A8/A9 protein (R&D Systems) at the indicated concentrations for specified durations.

    Techniques: Infection, Expressing, Mutagenesis, Quantitative RT-PCR, Control

    Extracellular S100A8/A9 functions as a potent pro-inflammatory stimulus for primary HBE cells. (A) Primary HBE cells were infected with WT K. pneumoniae (MOI 100) for the indicated time points. Relative mRNA expression of TLR4 was determined by qRT-PCR, with data calibrated to GAPDH and shown as fold induction over the baseline (0 h). (B) Representative western blot showing total TLR4 protein levels. β -Actin served as the housekeeping protein. (C) Quantification of TLR4 protein expression from three independent replicates, with values standardized to β-Actin. (D,E) HBE cells were treated for 24 h with the specified doses of endotoxin-free recombinant human S100A8/A9 (rS100A8/A9). The release of (D) IL-8 and (E) IL-6 was detected by ELISA. Data are presented as mean ± SEM of three independent experiments. * p < 0.05 versus the untreated control (A,C,D,E) .

    Journal: Frontiers in Microbiology

    Article Title: Klebsiella pneumoniae infection induces an S100A8/A9-mediated autocrine loop in human airway epithelium to amplify inflammation

    doi: 10.3389/fmicb.2026.1768140

    Figure Lengend Snippet: Extracellular S100A8/A9 functions as a potent pro-inflammatory stimulus for primary HBE cells. (A) Primary HBE cells were infected with WT K. pneumoniae (MOI 100) for the indicated time points. Relative mRNA expression of TLR4 was determined by qRT-PCR, with data calibrated to GAPDH and shown as fold induction over the baseline (0 h). (B) Representative western blot showing total TLR4 protein levels. β -Actin served as the housekeeping protein. (C) Quantification of TLR4 protein expression from three independent replicates, with values standardized to β-Actin. (D,E) HBE cells were treated for 24 h with the specified doses of endotoxin-free recombinant human S100A8/A9 (rS100A8/A9). The release of (D) IL-8 and (E) IL-6 was detected by ELISA. Data are presented as mean ± SEM of three independent experiments. * p < 0.05 versus the untreated control (A,C,D,E) .

    Article Snippet: For S100A8/A9 stimulating experiment, cells were incubated with endotoxin-free recombinant human S100A8/A9 protein (R&D Systems) at the indicated concentrations for specified durations.

    Techniques: Infection, Expressing, Quantitative RT-PCR, Western Blot, Recombinant, Enzyme-linked Immunosorbent Assay, Control

    Epithelial-derived S100A8/A9 is functionally required for the full inflammatory response to K. pneumoniae infection. Primary HBE cells were transfected with control siRNA (siCtrl) or S100A9 siRNA (siA9). (A) Knockdown efficiency was confirmed 48 h post-transfection by qRT-PCR analysis of S100A9 mRNA levels following a 12-h infection with WT K. pneumoniae (MOI 100), negative values represent fold reduction calculated as the negative inverse of 2 −ΔΔCt following the Schmittgen and Livak protocol. (B) Functional knockdown was confirmed by measuring S100A8/A9 protein secretion by ELISA in supernatants from infected cells at 24 h. (C,D) Control and S100A9 -deficient cells were infected with WT K. pneumoniae (MOI 100) for 24 h, and the secretion of cytokines were quantified by ELISA. Data are presented as mean ± SEM of three independent experiments. * p < 0.05 vs. Kp + siCtrl (A,B) or uninfected cells (C,D) , # p < 0.05 vs. Kp + siCtrl (C,D) .

    Journal: Frontiers in Microbiology

    Article Title: Klebsiella pneumoniae infection induces an S100A8/A9-mediated autocrine loop in human airway epithelium to amplify inflammation

    doi: 10.3389/fmicb.2026.1768140

    Figure Lengend Snippet: Epithelial-derived S100A8/A9 is functionally required for the full inflammatory response to K. pneumoniae infection. Primary HBE cells were transfected with control siRNA (siCtrl) or S100A9 siRNA (siA9). (A) Knockdown efficiency was confirmed 48 h post-transfection by qRT-PCR analysis of S100A9 mRNA levels following a 12-h infection with WT K. pneumoniae (MOI 100), negative values represent fold reduction calculated as the negative inverse of 2 −ΔΔCt following the Schmittgen and Livak protocol. (B) Functional knockdown was confirmed by measuring S100A8/A9 protein secretion by ELISA in supernatants from infected cells at 24 h. (C,D) Control and S100A9 -deficient cells were infected with WT K. pneumoniae (MOI 100) for 24 h, and the secretion of cytokines were quantified by ELISA. Data are presented as mean ± SEM of three independent experiments. * p < 0.05 vs. Kp + siCtrl (A,B) or uninfected cells (C,D) , # p < 0.05 vs. Kp + siCtrl (C,D) .

    Article Snippet: For S100A8/A9 stimulating experiment, cells were incubated with endotoxin-free recombinant human S100A8/A9 protein (R&D Systems) at the indicated concentrations for specified durations.

    Techniques: Derivative Assay, Infection, Transfection, Control, Knockdown, Quantitative RT-PCR, Functional Assay, Enzyme-linked Immunosorbent Assay

    TLR4 is the essential receptor mediating S100A8/A9-induced inflammation in HBE cells during K. pneumoniae infection. (A,B) HBE cells were pre-incubated with neutralizing antibodies against TLR4 (10 μg/mL), RAGE (100 μg/mL), or an isotype control (Iso Ctrl) for 1 h, followed by stimulation with recombinant human S100A8/A9 (20 μg/mL) for 24 h. Levels of (A) IL-8 and (B) IL-6 in supernatants were determined by ELISA. (C,D) HBE cells were pre-treated with the indicated antibodies for 1 h and subsequently infected with WT K. pneumoniae (MOI 100) for 24 h. Secretion of (C) IL-8 and (D) IL-6 was quantified by ELISA. All results are expressed as mean ± SEM of three independent experiments. * p < 0.05 compared with the indicated groups.

    Journal: Frontiers in Microbiology

    Article Title: Klebsiella pneumoniae infection induces an S100A8/A9-mediated autocrine loop in human airway epithelium to amplify inflammation

    doi: 10.3389/fmicb.2026.1768140

    Figure Lengend Snippet: TLR4 is the essential receptor mediating S100A8/A9-induced inflammation in HBE cells during K. pneumoniae infection. (A,B) HBE cells were pre-incubated with neutralizing antibodies against TLR4 (10 μg/mL), RAGE (100 μg/mL), or an isotype control (Iso Ctrl) for 1 h, followed by stimulation with recombinant human S100A8/A9 (20 μg/mL) for 24 h. Levels of (A) IL-8 and (B) IL-6 in supernatants were determined by ELISA. (C,D) HBE cells were pre-treated with the indicated antibodies for 1 h and subsequently infected with WT K. pneumoniae (MOI 100) for 24 h. Secretion of (C) IL-8 and (D) IL-6 was quantified by ELISA. All results are expressed as mean ± SEM of three independent experiments. * p < 0.05 compared with the indicated groups.

    Article Snippet: For S100A8/A9 stimulating experiment, cells were incubated with endotoxin-free recombinant human S100A8/A9 protein (R&D Systems) at the indicated concentrations for specified durations.

    Techniques: Infection, Incubation, Control, Recombinant, Enzyme-linked Immunosorbent Assay

    The S100A8/A9 autocrine loop drives NF-κB activation and subsequent cytokine release in HBE cells. (A) Representative immunoblots showing degradation of IκBα in primary HBE cells stimulated with rS100A8/A9 (20 μg/mL) for 60 min. β-Actin served as a loading control. (B) Densitometric quantification of IκBα protein levels from (A) . (C) Representative immunofluorescence images showing subcellular localization of the p65 subunit (green) at 60 min post-stimulation with rS100A8/A9. Nuclei were counterstained with DAPI (blue). (D) HBE cells were transfected with control siRNA (siCtrl) or siRNA targeting S100A9 (siS100A9) and subsequently infected with wild-type K. pneumoniae (MOI 100). Representative immunoblots of IκBα levels are shown at 60 min post-infection. (E) Densitometric quantification of IκBα degradation from (D) . (F) Representative immunofluorescence images showing p65 localization (green) in siCtrl- or siS100A9-transfected HBE cells at 60 min post- K. pneumoniae infection. Nuclei were stained with DAPI (blue). (G) Secretion of IL-8 and IL-6 by HBE cells. Cells were pre-treated with or without the NF-κB inhibitor BAY 11–7,082 (10 μM) for 60 min, followed by stimulation with rS100A8/A9 (20 μg/mL) for 24 h. Cytokine levels in supernatants were measured by ELISA. All graphs display mean ± SEM, * p < 0.05 compared with the untreated control (B,E,G) ; # p < 0.05 compared with siCtrl + Kp or the S100A8/A9-stimulated group without inhibitor (E,G) .

    Journal: Frontiers in Microbiology

    Article Title: Klebsiella pneumoniae infection induces an S100A8/A9-mediated autocrine loop in human airway epithelium to amplify inflammation

    doi: 10.3389/fmicb.2026.1768140

    Figure Lengend Snippet: The S100A8/A9 autocrine loop drives NF-κB activation and subsequent cytokine release in HBE cells. (A) Representative immunoblots showing degradation of IκBα in primary HBE cells stimulated with rS100A8/A9 (20 μg/mL) for 60 min. β-Actin served as a loading control. (B) Densitometric quantification of IκBα protein levels from (A) . (C) Representative immunofluorescence images showing subcellular localization of the p65 subunit (green) at 60 min post-stimulation with rS100A8/A9. Nuclei were counterstained with DAPI (blue). (D) HBE cells were transfected with control siRNA (siCtrl) or siRNA targeting S100A9 (siS100A9) and subsequently infected with wild-type K. pneumoniae (MOI 100). Representative immunoblots of IκBα levels are shown at 60 min post-infection. (E) Densitometric quantification of IκBα degradation from (D) . (F) Representative immunofluorescence images showing p65 localization (green) in siCtrl- or siS100A9-transfected HBE cells at 60 min post- K. pneumoniae infection. Nuclei were stained with DAPI (blue). (G) Secretion of IL-8 and IL-6 by HBE cells. Cells were pre-treated with or without the NF-κB inhibitor BAY 11–7,082 (10 μM) for 60 min, followed by stimulation with rS100A8/A9 (20 μg/mL) for 24 h. Cytokine levels in supernatants were measured by ELISA. All graphs display mean ± SEM, * p < 0.05 compared with the untreated control (B,E,G) ; # p < 0.05 compared with siCtrl + Kp or the S100A8/A9-stimulated group without inhibitor (E,G) .

    Article Snippet: For S100A8/A9 stimulating experiment, cells were incubated with endotoxin-free recombinant human S100A8/A9 protein (R&D Systems) at the indicated concentrations for specified durations.

    Techniques: Activation Assay, Western Blot, Control, Immunofluorescence, Transfection, Infection, Staining, Enzyme-linked Immunosorbent Assay

    The epithelial S100A8/A9 autocrine loop is a critical driver of neutrophil chemotaxis in response to K. pneumoniae infection. Neutrophil chemotaxis was assessed using a Transwell assay. (A) Comparison of the chemotactic activity of supernatants from uninfected HBE cells (conditioned medium, CM), HBE cells infected with WT K. pneumoniae (MOI 100), and fMLP (positive control) on primary human neutrophils. (B) Comparison of the chemotactic activity of supernatants from infected control (siCtrl) HBE cells versus infected S100A9-deficient (siS100A9) HBE cells. Flow cytometry was used to determine the absolute number of migrated neutrophils. Data are shown as mean ± SEM from three separate experiments. * p < 0.05 vs. uninfected CM, # p < 0.05 vs. Kp + siCtrl.

    Journal: Frontiers in Microbiology

    Article Title: Klebsiella pneumoniae infection induces an S100A8/A9-mediated autocrine loop in human airway epithelium to amplify inflammation

    doi: 10.3389/fmicb.2026.1768140

    Figure Lengend Snippet: The epithelial S100A8/A9 autocrine loop is a critical driver of neutrophil chemotaxis in response to K. pneumoniae infection. Neutrophil chemotaxis was assessed using a Transwell assay. (A) Comparison of the chemotactic activity of supernatants from uninfected HBE cells (conditioned medium, CM), HBE cells infected with WT K. pneumoniae (MOI 100), and fMLP (positive control) on primary human neutrophils. (B) Comparison of the chemotactic activity of supernatants from infected control (siCtrl) HBE cells versus infected S100A9-deficient (siS100A9) HBE cells. Flow cytometry was used to determine the absolute number of migrated neutrophils. Data are shown as mean ± SEM from three separate experiments. * p < 0.05 vs. uninfected CM, # p < 0.05 vs. Kp + siCtrl.

    Article Snippet: For S100A8/A9 stimulating experiment, cells were incubated with endotoxin-free recombinant human S100A8/A9 protein (R&D Systems) at the indicated concentrations for specified durations.

    Techniques: Chemotaxis Assay, Infection, Transwell Assay, Comparison, Activity Assay, Positive Control, Control, Flow Cytometry

    Proposed model of the S100A8/A9-mediated autocrine amplification loop in human airway epithelial cells during K. pneumoniae infection. Initial recognition of encapsulated K. pneumoniae by the airway epithelium triggers a primary transcriptional response, leading to the synthesis and secretion of the alarmin S100A8/A9 and a simultaneous upregulation of its cognate receptor, TLR4. This dual mechanism creates a primed state within the epithelium. The endogenously produced S100A8/A9 then acts back on the enriched TLR4 receptors in an autocrine or paracrine manner, activating the canonical NF-κB signaling pathway (characterized by IκB degradation and p65 nuclear translocation). This positive feedback loop significantly magnifies the production of pro-inflammatory cytokines such as IL-6 and IL-8, ultimately orchestrating massive neutrophil recruitment and driving the hyper-inflammation observed in severe pneumonia. Created in BioRender [You (2026) https://BioRender.com/qo9szis ].

    Journal: Frontiers in Microbiology

    Article Title: Klebsiella pneumoniae infection induces an S100A8/A9-mediated autocrine loop in human airway epithelium to amplify inflammation

    doi: 10.3389/fmicb.2026.1768140

    Figure Lengend Snippet: Proposed model of the S100A8/A9-mediated autocrine amplification loop in human airway epithelial cells during K. pneumoniae infection. Initial recognition of encapsulated K. pneumoniae by the airway epithelium triggers a primary transcriptional response, leading to the synthesis and secretion of the alarmin S100A8/A9 and a simultaneous upregulation of its cognate receptor, TLR4. This dual mechanism creates a primed state within the epithelium. The endogenously produced S100A8/A9 then acts back on the enriched TLR4 receptors in an autocrine or paracrine manner, activating the canonical NF-κB signaling pathway (characterized by IκB degradation and p65 nuclear translocation). This positive feedback loop significantly magnifies the production of pro-inflammatory cytokines such as IL-6 and IL-8, ultimately orchestrating massive neutrophil recruitment and driving the hyper-inflammation observed in severe pneumonia. Created in BioRender [You (2026) https://BioRender.com/qo9szis ].

    Article Snippet: For S100A8/A9 stimulating experiment, cells were incubated with endotoxin-free recombinant human S100A8/A9 protein (R&D Systems) at the indicated concentrations for specified durations.

    Techniques: Amplification, Infection, Produced, Translocation Assay